Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphoma.

Witzig TE, Maurer MJ, Stenson MJ, Allmer C, Macon W, Link B, Katzmann JA, Gupta M.

Am J Hematol. 2014 Apr;89(4):417-22. doi: 10.1002/ajh.23658. Epub 2014 Feb 10.

PMID:
24382707
[PubMed - indexed for MEDLINE]
2.

Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma.

Maurer MJ, Micallef IN, Cerhan JR, Katzmann JA, Link BK, Colgan JP, Habermann TM, Inwards DJ, Markovic SN, Ansell SM, Porrata LF, Johnston PB, Nowakowski GS, Thompson CA, Gupta M, Syrbu SI, Kurtin PJ, Macon WR, Nikcevich DA, Witzig TE.

J Clin Oncol. 2011 Apr 20;29(12):1620-6. doi: 10.1200/JCO.2010.29.4413. Epub 2011 Mar 7.

PMID:
21383282
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.

Ansell SM, Maurer MJ, Ziesmer SC, Slager SL, Habermann TM, Link BK, Witzig TE, Macon WR, Dogan A, Cerhan JR, Novak AJ.

Am J Hematol. 2012 Sep;87(9):865-9. doi: 10.1002/ajh.23259. Epub 2012 Jun 3.

PMID:
22674570
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma.

Jardin F, Delfau-Larue MH, Molina TJ, Copie-Bergman C, Brière J, Petrella T, Canioni D, Fabiani B, Jais JP, Figeac M, Leroy K, Mareschal S, Salles GA, Coiffier B, Delarue R, Peyrade F, Bosly A, André M, Ketterer N, Haioun C, Tilly H.

Leuk Lymphoma. 2013 Sep;54(9):1898-907. doi: 10.3109/10428194.2013.767456. Epub 2013 Feb 18.

PMID:
23327290
[PubMed - indexed for MEDLINE]
5.

Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia.

Maurer MJ, Cerhan JR, Katzmann JA, Link BK, Allmer C, Zent CS, Call TG, Rabe KG, Hanson CA, Kay NE, Slager SL, Witzig TE, Shanafelt TD.

Blood. 2011 Sep 8;118(10):2821-6. doi: 10.1182/blood-2011-04-349134. Epub 2011 Jul 15.

PMID:
21765023
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Monoclonal and polyclonal gammopathy measured by serum free light chain and immunofixation subdivide the clinical outcomes of diffuse large B-cell lymphoma according to molecular classification.

Kim YR, Kim SJ, Cheong JW, Kim Y, Jang JE, Lee JY, Min YH, Song JW, Yang WI, Kim JS.

Ann Hematol. 2014 Jun 20. [Epub ahead of print]

PMID:
24947797
[PubMed - as supplied by publisher]
7.

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma.

Thompson CA, Maurer MJ, Cerhan JR, Katzmann JA, Ansell SM, Habermann TM, Macon WR, Weiner GJ, Link BK, Witzig TE.

Am J Hematol. 2011 Dec;86(12):998-1000. doi: 10.1002/ajh.22168. Epub 2011 Oct 17.

PMID:
22006790
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.

Giachelia M, Voso MT, Tisi MC, Martini M, Bozzoli V, Massini G, D'Aló F, Larocca LM, Leone G, Hohaus S.

Leuk Lymphoma. 2012 Mar;53(3):411-6. doi: 10.3109/10428194.2011.621566. Epub 2011 Oct 24.

PMID:
21902578
[PubMed - indexed for MEDLINE]
9.

Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms.

Pardanani A, Lasho TL, Finke CM, Rajkumar SV, Singh PP, Ketterling RP, Hanson CA, Katzmann JA, Tefferi A.

J Clin Oncol. 2012 Apr 1;30(10):1087-94. doi: 10.1200/JCO.2011.39.0310. Epub 2012 Feb 13.

PMID:
22331938
[PubMed - indexed for MEDLINE]
10.

Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP.

Huang X, Meng B, Iqbal J, Ding BB, Perry AM, Cao W, Smith LM, Bi C, Jiang C, Greiner TC, Weisenburger DD, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Gascoyne RD, Cook JR, Tubbs RR, Jaffe ES, Armitage JO, Vose JM, Staudt LM, McKeithan TW, Chan WC, Ye BH, Fu K.

J Clin Oncol. 2013 Dec 20;31(36):4520-8. doi: 10.1200/JCO.2012.45.6004. Epub 2013 Nov 12.

PMID:
24220563
[PubMed - indexed for MEDLINE]
11.

Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation.

Gupta M, Han JJ, Stenson M, Maurer M, Wellik L, Hu G, Ziesmer S, Dogan A, Witzig TE.

Blood. 2012 Mar 22;119(12):2844-53. doi: 10.1182/blood-2011-10-388538. Epub 2012 Feb 8.

PMID:
22323454
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy.

Wang L, Liu P, Chen X, Geng Q, Lu Y.

Med Oncol. 2012 Sep;29(3):2153-8. doi: 10.1007/s12032-011-0049-z. Epub 2011 Aug 30.

PMID:
21877195
[PubMed - indexed for MEDLINE]
13.

The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).

Bavi P, Uddin S, Bu R, Ahmed M, Abubaker J, Balde V, Qadri Z, Ajarim D, Al-Dayel F, Hussain AR, Al-Kuraya KS.

J Pathol. 2011 Jul;224(3):355-66. doi: 10.1002/path.2864. Epub 2011 Apr 19.

PMID:
21506127
[PubMed - indexed for MEDLINE]
14.

Prognostic markers in diffuse large B-cell lymphoma: Keys to the underlying biology.

Winter JN.

Curr Hematol Malig Rep. 2007 Oct;2(4):235-41. doi: 10.1007/s11899-007-0032-0. Review.

PMID:
20425375
[PubMed - indexed for MEDLINE]
15.

Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.

Porrata LF, Ristow K, Habermann TM, Witzig TE, Inwards DJ, Markovic SN.

Am J Hematol. 2009 Feb;84(2):93-7. doi: 10.1002/ajh.21337.

PMID:
19123458
[PubMed - indexed for MEDLINE]
16.

Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.

Campbell JP, Cobbold M, Wang Y, Goodall M, Bonney SL, Chamba A, Birtwistle J, Plant T, Afzal Z, Jefferis R, Drayson MT.

J Immunol Methods. 2013 May 31;391(1-2):1-13. doi: 10.1016/j.jim.2013.01.014. Epub 2013 Feb 4.

PMID:
23388695
[PubMed - indexed for MEDLINE]
Free Article
17.

Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index.

Lech-Maranda E, Bienvenu J, Broussais-Guillaumot F, Warzocha K, Michallet AS, Robak T, Coiffier B, Salles G.

Arch Immunol Ther Exp (Warsz). 2010 Apr;58(2):131-41. doi: 10.1007/s00005-010-0066-1. Epub 2010 Feb 27.

PMID:
20191326
[PubMed - indexed for MEDLINE]
18.

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR.

Am J Surg Pathol. 2010 Mar;34(3):327-40. doi: 10.1097/PAS.0b013e3181cd3aeb.

PMID:
20118770
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP.

Gupta M, Maurer MJ, Wellik LE, Law ME, Han JJ, Ozsan N, Micallef IN, Dogan A, Witzig TE.

Blood. 2012 Nov 22;120(22):4400-6. doi: 10.1182/blood-2012-05-428466. Epub 2012 Sep 27.

PMID:
23018644
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Serum polyclonal immunoglobulin free light chain levels predict mortality in people with chronic kidney disease.

Hutchison CA, Burmeister A, Harding SJ, Basnayake K, Church H, Jesky MD, White K, Green CE, Stringer SJ, Bassett P, Ferro CJ, Cockwell P.

Mayo Clin Proc. 2014 May;89(5):615-22. doi: 10.1016/j.mayocp.2014.01.028.

PMID:
24797643
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk